Latest Breaking News On - Chronic inducible urticaria - Page 1 : comparemela.com

Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 - Jasper Therapeutics (NASDAQ:JSPR)

REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting

United statesLauren walkerAlex grayJoyce allaireEdwin tuckerEuropean academy of allergyJasper therapeutics incSingle subcutaneous sc administration to healthyEuropean academyClinical immunologyKit mouseWendy pangSenior vice presidentTranslational medicineChief medical officerDose escalation study

Jasper Therapeutics to Present Data on Briquilimab in Mast

Jasper Therapeutics to Present Data on Briquilimab in Mast
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesAlex grayJoyce allaireEdwin tuckerLauren walkerEuropean academy of allergySingle subcutaneous sc administration to healthyJasper therapeutics incEuropean academyClinical immunologyKit mouseWendy pangSenior vice presidentTranslational medicineChief medical officerDose escalation study

Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024

Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLauren walkerEdwin tuckerAlex grayJoyce allaireSingle subcutaneous sc administration to healthyEuropean academy of allergyJasper therapeutics incPresent dataMast cell driven diseasesEuropean academyClinical immunologyKit mouseWendy pangSenior vice presidentTranslational medicine

Jasper Therapeutics (JSPR) Announces Pricing of $50 Million Underwritten Offering of Common Stock

Jasper Therapeutics (JSPR) Announces Pricing of $50 Million Underwritten Offering of Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Great point partnersJasper therapeutics incJasper therapeuticsChronic inducible urticariaAvidity partnersBoxer capitalQiming venture partners united statesRock springs capitalSamsara biocapitalSoleus capitalVelan capitalWoodline capital

Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock

REDWOOD CITY, Calif., Feb. 06, 2024 Jasper Therapeutics, Inc. , a clinical-stage biotechnology company focused on developing novel antibody therapies targeting c-Kit to address diseases such.

New yorkUnited statesAlex grayLauren walkerJoyce allaireEvercore groupExchange commissionGreat point partnersGlobenewswire incJasper therapeutics incChronic inducible urticariaAvidity partnersPoint partnersVenture partners united statesSprings capitalSamsara biocapital